KFP
GSK icon

Keener Financial Planning’s GSK GSK Stock Holding History

Keener Financial Planning’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46
Closed -$1K – 110
2025
Q3 		$1K Hold
46
– – ﹤0.01% 204
2025
Q2 		$1K Hold
46
– – ﹤0.01% 205
2025
Q1 		$1K Hold
46
– – ﹤0.01% 168
2024
Q4 		$1K Hold
46
– – ﹤0.01% 170
2024
Q3 		$1K Hold
46
– – ﹤0.01% 175
2024
Q2 		$1K Hold
46
– – ﹤0.01% 180
2024
Q1 		$2K Hold
46
– – ﹤0.01% 181
2023
Q4 		$2K Buy
+46
New +$1.65K ﹤0.01% 177

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Keener Financial Planning's GSK Position: Q4 2025 in Review

Keener Financial Planning sold out of GSK (GSK) in Q4 2025, closing a stake of 46 shares — an estimated $1K sold.

Keener Financial Planning first reported a position in GSK in Q4 2023 and held it in 8 quarters. The position peaked at $2K in Q1 2024. 998 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Keener Financial Planning reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Keener Financial Planning sold 46 GSK shares in Q4 2025, an estimated $1K.
  • Keener Financial Planning first reported a position in GSK in Q4 2023 and held it in 8 quarters.
  • Keener Financial Planning's GSK position peaked at $2K in Q1 2024.
  • 998 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Keener Financial Planning's 13F filing for Q4 2025, filed 23 Jan 2026.